10.2967/jnumed.122.263838
10.2967/jnumed.122.263838 · doi-reference
Development of [18F]MIPS15692, a radiotracer with in vitro proof-of-concept for the imaging of MER tyrosine kinase (MERTK) in neuroinflammatory disease
10.1016/j.ejmech.2021.113822 · doi-reference
Synthesis, biodistribution and in vitro evaluation of brain permeable high affinity type 2 cannabinoid receptor agonists [11C]MA2 and [18F]MA3
10.3389/fnins.2016.00431 · doi-reference
Preclinical evaluation of [11C]NE40, a type 2 cannabinoid receptor PET tracer
10.1016/j.nucmedbio.2011.09.005 · doi-reference
10.3390/ijms22010019
10.3390/ijms22010019 · doi-reference
[11C]JNJ54173717, a novel P2X7 receptor radioligand as marker for neuroinflammation: human biodistribution, dosimetry, brain kinetic modelling and quantification of brain P2X7 receptors in patients with Parkinson’s disease and healthy volunteers
10.1007/s00259-019-04369-6 · doi-reference
Spotlight on P2X7 receptor PET imaging: a bright target or a failing star?
10.3390/ijms24021374 · doi-reference
First-in-human healthy volunteer dosimetry studies of the excitatory amino acid transporter 2 (EAAT2) PET imaging tracer methyl N4-(7-[18F]fluoro-9H-fluoren-2-yl)asparaginate, [18F]RP-115
10.1016/j.nucmedbio.2025.108992 · doi-reference
10.1073/pnas.1812155116
10.1073/pnas.1812155116 · doi-reference
Spatiotemporal transcriptomic mapping reveals region-specific glial activation and astrocyte shifts in epileptogenesis beyond the hippocampus
10.1186/s40478-026-02224-y · doi-reference
10.1111/epi.16956
10.1111/epi.16956 · doi-reference
Increased uptake of the P2X7 receptor radiotracer 18F-JNJ-64413739 in the brain and peripheral organs according to the severity of status epilepticus in male mice
10.1111/epi.17484 · doi-reference
Longitudinal positron emission tomography imaging with P2X7 receptor-specific radioligand 18F-FTTM in a kainic acid rat model of temporal lobe epilepsy
10.1021/acschemneuro.2c00557 · doi-reference
More than a drug target: Purinergic signalling as a source for diagnostic tools in epilepsy
10.1016/j.neuropharm.2022.109303 · doi-reference
The Multifaceted role of P2X7R in microglia and astrocytes
10.1007/s11064-025-04502-y · doi-reference
Ex vivo characterization of neuroinflammatory and neuroreceptor changes during epileptogenesis using candidate positron emission tomography biomarkers
10.1111/epi.16353 · doi-reference
Positron emission tomography with [11C]deuterium-deprenyl in temporal lobe epilepsy
10.1111/j.1528-1157.1995.tb01051.x · doi-reference
Monoamine oxidase B in astrocytic GABA synthesis: a central mechanism in neurodegeneration and neuroinflammation
10.33696/signaling.6.134 · doi-reference
10.2967/jnumed.112.116228
10.2967/jnumed.112.116228 · doi-reference
Radiosynthesis and in vivo evaluation of [11C]A1070722, a high affinity GSK-3 PET tracer in primate brain
10.1021/acschemneuro.6b00376 · doi-reference
In vivo imaging and kinetic modeling of novel glycogen synthase kinase-3 radiotracers [11C]OCM-44 and [18F]OCM-50 in non-human primates
10.3390/ph16020194 · doi-reference
Synthesis and evaluation of [11C]PyrATP-1, a novel radiotracer for PET imaging of glycogen synthase kinase-3β (GSK-3β)
10.1016/j.nucmedbio.2014.03.025 · doi-reference
Radiolabeling of [11C]FPS-ZM1, a receptor for advanced glycation end products-targeting positron emission tomography radiotracer, using a [11C]CO2-to-[11C]CO chemical conversion
10.4155/fmc-2019-0329 · doi-reference
Strategies for PET imaging of the receptor for advanced glycation endproducts (RAGE)
10.1016/j.jpha.2020.07.009 · doi-reference
Synthesis and evaluation of [18F]RAGER: a first generation small-molecule PET radioligand targeting the receptor for advanced glycation endproducts
10.1021/acschemneuro.5b00319 · doi-reference
